Categories AlphaGraphs, Earnings, Technology
TWTR Earnings: Twitter Q4 profit, revenue miss estimates
Microblogging platform Twitter (NYSE: TWTR) on Thursday reported weaker-than-expected earnings and revenues for the fourth quarter of 2021. The company’s stock dropped soon after the announcement.
Fourth-quarter earnings, adjusted for special items, declined to $0.33 per share from $0.38 per share last year and came in below the consensus forecast. The company reported a net profit of $181.7 million or $0.21 per share for the December quarter, compared to $222.1 million or $0.27 per share in the year-ago period.
The bottom-line performance was negatively impacted by a sharp increase in operating expenses. Meanwhile, revenues moved up 22% annually to $1.57 billion during the three-month period. Analysts had predicted a faster growth. The average monetizable daily active usage was 217 million.
Read management/analysts’ comments on Twitter’s Q4 earnings
Twitter stock has lost about13% so far this year and is currently trading well below the 52-week average. The shares traded lower in early trading on Thursday soon after the earnings announcement.
Prior Performance
Most Popular
Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report
Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,
J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights
The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs
